Tamir Mosharrafa, MD
Plastic and Reconstructive Surgery · Phoenix, AZNPI 1801832977
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $136,750 of the $159,705 with a category attached, or 85.6%. 11 manufacturers reported payments, led by Mentor Worldwide LLC at 52.0% of the total. 2025 is the largest year on record at $78,043, 8.2 times the $9,521 reported in 2019. Among plastic and reconstructive surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $854.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mentor Worldwide LLC$83K
- Medical Device Business Services, Inc.$76K
- AbbVie$534
- Musculoskeletal Transplant Foundation Inc.$190
- TELA Bio, Inc.$144
- Tepha Inc$87
- plus $172 from 5 others
Across 73 payments — averaging $691.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mentor Worldwide LLC$44K
- Medical Device Business Services, Inc.$6K
What the payments were for
- Consulting fees$136,75086%
- Speaking & faculty fees$4,2003%
- Travel & lodging$13,9819%
- Food & beverage$4,7743%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mentor Worldwide LLC | 108 | $83,056 |
| Medical Device Business Services, Inc. | 37 | $75,523 |
| AbbVie(2 entities) | 27 | $534 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $190 |
| TELA Bio, Inc. | 3 | $144 |
| Tepha Inc | 1 | $87 |
| Apyx Medical Corporation | 1 | $51 |
| Pacira Pharmaceuticals Incorporated | 2 | $45 |
| Boston Scientific | 2 | $28 |
| Davol Inc. | 1 | $24 |
| Sientra, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$159,705 in reported general payments places this provider in the 95th percentile of 63 plastic and reconstructive surgery providers in Arizona.
See all plastic and reconstructive surgery providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $241 |
| Ondansetron OdtOndansetron | 26 | $151 |
| Cephalexin | 36 | $148 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Phoenix
- Ha ChimPhoenix$355K
- Marc GottliebPhoenix$27K
- Randall CraftPhoenix$20K
- Jinesh ShahPhoenix$14K
- Martin BenjaminPhoenix$6K
- Ali MosharrafaPhoenix$5K
- Ashkaun ShaterianPhoenix$3K
- Jason MussmanPhoenix$2K
- Tim MatatovPhoenix$1K
- Travis HolcombePhoenix$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.